HK42696A - Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid - Google Patents
Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid Download PDFInfo
- Publication number
- HK42696A HK42696A HK42696A HK42696A HK42696A HK 42696 A HK42696 A HK 42696A HK 42696 A HK42696 A HK 42696A HK 42696 A HK42696 A HK 42696A HK 42696 A HK42696 A HK 42696A
- Authority
- HK
- Hong Kong
- Prior art keywords
- clavulanic acid
- amino
- pharmaceutically acceptable
- acceptable salts
- producing pharmaceutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0047292A AT400033B (de) | 1992-03-10 | 1992-03-10 | Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK42696A true HK42696A (en) | 1996-03-22 |
Family
ID=3491521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK42696A HK42696A (en) | 1992-03-10 | 1996-03-14 | Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US20010036940A1 (ja) |
| JP (2) | JP2817563B2 (ja) |
| CN (3) | CN1045604C (ja) |
| AT (1) | AT400033B (ja) |
| AU (1) | AU659282B2 (ja) |
| CH (1) | CH685054A5 (ja) |
| CY (1) | CY1995A (ja) |
| DE (1) | DE4307422B4 (ja) |
| DK (1) | DK26093A (ja) |
| ES (1) | ES2058029B1 (ja) |
| FI (1) | FI101965B1 (ja) |
| FR (1) | FR2688506B1 (ja) |
| GB (1) | GB2264944B (ja) |
| GR (1) | GR1002329B (ja) |
| HK (1) | HK42696A (ja) |
| IE (1) | IE70926B1 (ja) |
| IT (1) | IT1261213B (ja) |
| NL (1) | NL9300430A (ja) |
| NO (1) | NO301372B1 (ja) |
| SE (1) | SE508043C2 (ja) |
| TW (1) | TW364907B (ja) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT399155B (de) * | 1992-03-26 | 1995-03-27 | Lek Tovarna Farmacevtskih | Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung |
| SI9300296B (sl) * | 1992-06-11 | 1998-06-30 | Smithkline Beecham P.L.C. | Postopek in intermedianti za pripravo klavulanske kisline |
| KR100200239B1 (ko) * | 1992-10-21 | 1999-06-15 | 김충환 | 클라불란산 칼륨염의 제조방법 |
| EP0658558B1 (en) | 1993-11-17 | 2001-01-24 | Biochemie Gesellschaft M.B.H. | Separation of cephalosporin isomers |
| GB9426261D0 (en) * | 1994-12-24 | 1995-02-22 | Spurcourt Ltd | Clavulanic acid salts |
| CZ266697A3 (en) * | 1995-02-25 | 1997-11-12 | Spurcourt Ltd | Salts of clavulanic acid |
| KR100200242B1 (ko) * | 1995-05-16 | 1999-06-15 | 김충환 | 클라불란산염의 제조 방법 |
| AT403375B (de) * | 1995-11-15 | 1998-01-26 | Biochemie Gmbh | Verfahren zur fällung von alkalisalzen der clavulansäure |
| WO2000004028A1 (en) * | 1998-07-16 | 2000-01-27 | Dsm N.V. | Improved process for the preparation of salts and esters of clavulanic acid |
| ATE260096T1 (de) * | 1999-04-01 | 2004-03-15 | Dsm Ip Assets Bv | Agglomerate durch kristallisation |
| BRPI0110774B8 (pt) * | 2000-05-13 | 2021-05-25 | Smithkline Beecham Plc | processo para purificação de um sal de ácido clavulânico |
| CN101351213B (zh) * | 2005-09-07 | 2013-10-02 | 詹纳里克斯公司 | 使用表达gm-csf的痘病毒系统性治疗转移性癌和/或全身散布性癌 |
| JP7028064B2 (ja) | 2018-05-30 | 2022-03-02 | 横河電機株式会社 | 機器保全装置、機器保全方法、機器保全プログラム及び記録媒体 |
| WO2022008876A1 (en) | 2020-07-10 | 2022-01-13 | Carbon Clean Solutions Limited | A method and system for the removal of carbon dioxide from solvents using low-grade heat |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3288800A (en) * | 1962-05-29 | 1966-11-29 | Squibb & Sons Inc | Schiff's bases of 6-amino-penicillanic acid and purification of 6-aminopenicillanic acid by the use thereof |
| GB1508977A (en) | 1974-04-20 | 1978-04-26 | Beecham Group Ltd | Beta-lactam antibiotic from streptomyces clavuligerus |
| IE41109B1 (en) * | 1974-04-20 | 1979-10-24 | Beecham Group Ltd | Novel -lactam antibiotic from streptomyces clavuligerus |
| US4110165A (en) * | 1974-04-20 | 1978-08-29 | Beecham Group Limited | Process for the production of clavulanic acid |
| US4144242A (en) * | 1975-02-07 | 1979-03-13 | Glaxo Laboratories Limited | Process for the purification of clavulanic acid |
| GB1543563A (en) | 1975-02-07 | 1979-04-04 | Glaxo Lab Ltd | Beta-lactam antibiotic in purified form |
| GB1561395A (en) | 1976-02-26 | 1980-02-20 | Beecham Group Ltd | -lactam antibiotic |
| GB1578739A (en) * | 1976-07-23 | 1980-11-05 | Beecham Group Ltd | Amine salts of clavulanic acid methods for their preparation and compositions containing them |
| GB2003863B (en) | 1977-09-01 | 1982-03-31 | Beecham Group Ltd | Chemical process |
| DE2861607D1 (en) | 1977-11-26 | 1982-03-11 | Beecham Group Plc | Derivatives of clavulanic acid and pharmaceutical compositions containing them |
| BE862211A (fr) * | 1977-12-22 | 1978-06-22 | Beecham Group Ltd | Agents antibacteriens |
| DE3063683D1 (en) * | 1979-08-24 | 1983-07-14 | Beecham Group Plc | Amine salt of clavulanic acid, its preparation and use |
| US4454069A (en) * | 1979-08-24 | 1984-06-12 | Beecham Group Limited | Clavulanic acid salts and their preparation from the tertiary butyl amine salt |
| AU600655B2 (en) | 1984-10-27 | 1990-08-23 | Beecham Group Plc | Preparation of clavulanic acid and its salts and esters |
| GB8618888D0 (en) * | 1986-08-01 | 1986-09-10 | Davy Mckee Ltd | Process |
| US5679789A (en) * | 1987-01-29 | 1997-10-21 | Beecham Group, P.L.C. | Pharmaceutical compositions comprising potassium clavulanate and methods of using them |
| GB2200355B (en) | 1987-01-29 | 1990-08-01 | Beecham Group Plc | Potassium clavulanate |
| ES2010143A6 (es) * | 1989-03-01 | 1989-10-16 | Pharma Mar S A Pharmar | Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp. |
| US5210296A (en) * | 1990-11-19 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Recovery of lactate esters and lactic acid from fermentation broth |
| AT399155B (de) * | 1992-03-26 | 1995-03-27 | Lek Tovarna Farmacevtskih | Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung |
| SI9300296B (sl) | 1992-06-11 | 1998-06-30 | Smithkline Beecham P.L.C. | Postopek in intermedianti za pripravo klavulanske kisline |
| SI9200139A (en) * | 1992-07-08 | 1994-03-31 | Lek Tovarna Farmacevtskih | New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them |
| KR100200239B1 (ko) | 1992-10-21 | 1999-06-15 | 김충환 | 클라불란산 칼륨염의 제조방법 |
| GB9401969D0 (en) | 1994-02-02 | 1994-03-30 | Smithkline Beecham Plc | Process |
| SI9400107A (en) | 1994-03-02 | 1995-10-31 | Lek Tovarna Farmacevtskih | New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804. |
| GB2298201B (en) | 1995-02-25 | 1997-05-28 | Spurcourt Ltd | Clavulanic acid salts |
| CZ266697A3 (en) * | 1995-02-25 | 1997-11-12 | Spurcourt Ltd | Salts of clavulanic acid |
| SI9500074A (en) | 1995-03-10 | 1996-10-31 | Lek Tovarna Farmacevtskih | Process for preparation of alkani salts of clavulanic acid. |
| SI9500134B (sl) | 1995-04-20 | 2004-04-30 | Lek, | Postopek za pripravo čistih alkalijskih soli klavulanske kisline |
| KR100200242B1 (ko) * | 1995-05-16 | 1999-06-15 | 김충환 | 클라불란산염의 제조 방법 |
| GB9515809D0 (en) | 1995-08-02 | 1995-10-04 | Smithkline Beecham Plc | Process |
| SI9500265A1 (en) | 1995-08-28 | 1997-02-28 | Lek Tovarna Farmacevtskih | Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration |
| US6414142B1 (en) | 1996-06-13 | 2002-07-02 | Smithkline Beecham Corporation | Process for preparing potassium clavulanate |
| WO1998021212A1 (en) | 1996-11-11 | 1998-05-22 | Gist-Brocades B.V. | Process for the preparation of salts and esters of clavulanic acid |
-
1992
- 1992-03-10 AT AT0047292A patent/AT400033B/de not_active IP Right Cessation
-
1993
- 1993-03-05 CH CH670/93A patent/CH685054A5/de not_active IP Right Cessation
- 1993-03-08 GB GB9304704A patent/GB2264944B/en not_active Expired - Fee Related
- 1993-03-08 JP JP5046691A patent/JP2817563B2/ja not_active Expired - Fee Related
- 1993-03-08 NO NO930829A patent/NO301372B1/no unknown
- 1993-03-08 SE SE9300758A patent/SE508043C2/sv not_active IP Right Cessation
- 1993-03-09 CN CN93102897A patent/CN1045604C/zh not_active Expired - Fee Related
- 1993-03-09 AU AU34070/93A patent/AU659282B2/en not_active Ceased
- 1993-03-09 DK DK026093A patent/DK26093A/da not_active Application Discontinuation
- 1993-03-09 GR GR930100090A patent/GR1002329B/el not_active IP Right Cessation
- 1993-03-09 FI FI931032A patent/FI101965B1/fi active
- 1993-03-09 IE IE930172A patent/IE70926B1/en not_active IP Right Cessation
- 1993-03-09 DE DE4307422A patent/DE4307422B4/de not_active Expired - Fee Related
- 1993-03-09 FR FR9302720A patent/FR2688506B1/fr not_active Expired - Fee Related
- 1993-03-10 ES ES09300483A patent/ES2058029B1/es not_active Expired - Fee Related
- 1993-03-10 NL NL9300430A patent/NL9300430A/nl active Search and Examination
- 1993-03-10 IT ITRM930147A patent/IT1261213B/it active IP Right Grant
- 1993-05-04 TW TW082103491A patent/TW364907B/zh not_active IP Right Cessation
-
1996
- 1996-03-14 HK HK42696A patent/HK42696A/xx not_active IP Right Cessation
- 1996-06-29 CN CN96108278A patent/CN1150153A/zh active Pending
- 1996-06-29 CN CN96108276A patent/CN1145906A/zh active Pending
-
1997
- 1997-08-13 JP JP9218732A patent/JPH1067785A/ja active Pending
- 1997-09-05 CY CY199597A patent/CY1995A/en unknown
-
2001
- 2001-06-26 US US09/892,179 patent/US20010036940A1/en not_active Abandoned
-
2002
- 2002-02-08 US US10/071,364 patent/US20020072513A1/en not_active Abandoned
- 2002-09-20 US US10/251,948 patent/US20030022882A1/en not_active Abandoned
-
2003
- 2003-05-13 US US10/437,097 patent/USH2158H1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT69374A (en) | Novel process for the preparation of clavulanic acid, its pharmaceutically salts and esters | |
| CA2046998A1 (en) | Method of producing liposomal products | |
| AU3954589A (en) | The production of formate salts of nitrogenous bases | |
| AU3266189A (en) | Pyridone carboxylic acid derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same | |
| ES2058029A1 (es) | Proceso para la produccion de sales del acido clavulanico. | |
| ES2042534T3 (es) | Un proceso para la preparacion de una preparacion topica en forma de un hidrogel. | |
| NO301767B1 (no) | Salt av clavulansyre | |
| PT81370B (de) | 1,2,4-triazolo-carbamate und ihre saeureadditionssalze verfahren zu ihrer herstellung und arzneimittel | |
| AU6740296A (en) | Process for the preparation of potassium clavulanate | |
| AU9142091A (en) | Process for the preparation of derivatives of 3,5-dihydroxy pentanoic acid | |
| AU9004591A (en) | 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof | |
| IE813100L (en) | Naphthyridine derivatives | |
| IE810808L (en) | Isophthalic acid picolylamide monohydrate | |
| AU7018394A (en) | Pyrrolo{3,2-b}pyridinylalkyl benzamide derivatives | |
| IE810311L (en) | Guanylamidines. | |
| HUT50476A (en) | Process for producing 3-pyrrolidinyl-thio-1-azabicyclo/3,2,0/hept-2-ene-2-carboxylic acid derivatives | |
| RU93004798A (ru) | Новые азетидиновые производные пиридонкарбоновых кислот, способ их получения, фармацевтическая композиция на их основе и использование | |
| AU1016288A (en) | 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives | |
| EP0552019A3 (en) | Method of producing 1,4-dihydroxy-2-naphthoic acid | |
| GR3021347T3 (en) | Diamine salts of clavulanic acid. | |
| SI0711350T1 (en) | Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid | |
| IL111317A (en) | Process for preparing N-(2,6-dichloro-3-methylphenyl)-5,7-dihalo¬1,2,4¾-triazolo¬1,5-a¾pyrimidine-2-sulfonamide by cyclization of the corresponding 5-amino¬1,2,4¾triazole-3-sulfonamide with malonic acid and halo-dehydroxylation of the product | |
| HU914020D0 (en) | Process for the production of d1, d, and 1/1,2,3,4/tetrahydro-izokynoline-1-carbonic acid and its uretane type derivatives with n-protection group | |
| AU619124C (en) | Salts of N5,N10-methylene-5,6,7,8-tetrahydrofolic acid | |
| ZA886870B (en) | L-dopa derivatives or their acid addition salts,process for producing same and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| AS | Change of ownership |
Owner name: SANDOZ AG Free format text: FORMER OWNER(S): SANDOZ GMBH |
|
| CHPA | Change of a particular in the register (except of change of ownership) | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100308 |